This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cancer Neoantigen Vaccines
February 2, 2023 | 1-Day Digital Conference
Digital Conference8:00AM EST // 1:00PM GMT // 2:00PM CET
Menu

Eric Halioua
CEO at PDC*Line Pharma
Speaker

Agenda Sessions

  • New class of Antigen-specific Cancer Active Immunotherapies based on an off-the-shelf Antigen Presenting Cell line (PDC*line)

    , 08:35
    View Session

At this event

Prev
Next
Brandon Malone
Principal Data Scientist
NEC Oncolmmunity As

See Eric at Cancer Neoantigen Vaccines